| 1 |
34607230 | The role of lovastatin in the attenuation of COVID-19. | 2021 Dec |
1 |
| 2 |
31628482 | A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. | 2020 Jul 1 |
4 |
| 3 |
33224343 | Statins and C-reactive protein: in silico evidence on direct interaction. | 2020 |
1 |
| 4 |
19395785 | C-reactive protein level following treatment and withdrawal of lovastatin in diabetic nephropathy. | 2009 Apr |
7 |
| 5 |
19571581 | Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. | 2009 |
1 |
| 6 |
15694950 | Lovastatin compromises C-reactive protein induced endothelial dysfunction including altered expression of cell adhesion molecules and increased monocyte recruitment. | 2005 Feb |
1 |
| 7 |
16141529 | Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells. | 2005 Sep |
2 |
| 8 |
15540478 | HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. | 2004 Aug 15 |
1 |
| 9 |
12008177 | Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. | 2002 May 15 |
1 |
| 10 |
11430324 | Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. | 2001 Jun 28 |
3 |